| 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Arthritis & rheumatology 68 (3), 566-576, 2016 | 920 | 2016 |
| A new set of criteria for the diagnosis of familial Mediterranean fever in childhood F Yalçınkaya, S Özen, ZB Özçakar, N Aktay, N Çakar, A Düzova, ... Rheumatology 48 (4), 395-398, 2009 | 622 | 2009 |
| Rheumatic disease and COVID-19: epidemiology and outcomes KL Hyrich, PM Machado Nature Reviews Rheumatology 17 (2), 71-72, 2021 | 188 | 2021 |
| Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine S Özen, Y Bilginer, NA Ayaz, M Calguneri The Journal of rheumatology 38 (3), 516-518, 2011 | 173 | 2011 |
| Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study A Consolaro, G Giancane, A Alongi, EHP van Dijkhuizen, A Aggarwal, ... The Lancet Child & Adolescent Health 3 (4), 255-263, 2019 | 170 | 2019 |
| Abatacept as a long-term targeted therapy for LRBA deficiency A Kiykim, I Ogulur, E Dursun, LM Charbonnier, E Nain, S Cekic, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (8), 2790-2800 …, 2019 | 152 | 2019 |
| Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease S Ozen, N Aktay, E Lainka, A Duzova, A Bakkaloglu, T Kallinich Annals of the rheumatic diseases 68 (2), 246-248, 2009 | 138 | 2009 |
| Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease Y Bilginer, NA Ayaz, S Ozen Clinical rheumatology 29, 209-210, 2010 | 127 | 2010 |
| MEFV mutations in systemic onset juvenile idiopathic arthritis NA Ayaz, S Özen, Y Bilginer, M Ergüven, E Taşkıran, E Yılmaz, N Beşbaş, ... Rheumatology 48 (1), 23-25, 2009 | 110 | 2009 |
| Paediatric rheumatology E Demirkaya, S Ozen, Y Bilginer, NA Ayaz, BB Makay, E Unsal, ... Clinical and experimental rheumatology 29, 111-116, 2011 | 105 | 2011 |
| Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis F Minoia, S Davì, AC Horne, F Bovis, E Demirkaya, J Akikusa, NA Ayaz, ... The Journal of rheumatology 42 (6), 994-1001, 2015 | 83 | 2015 |
| Development and initial validation of the macrophage activation syndrome/primary hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary … F Minoia, F Bovis, S Davi, A Insalaco, K Lehmberg, S Shenoi, S Weitzman, ... The Journal of pediatrics 189, 72-78. e3, 2017 | 68 | 2017 |
| FMF50: a score for assessing outcome in familial Mediterranean fever S Ozen, E Demirkaya, A Duzova, O Erdogan, E Erken, A Gul, ... Annals of the rheumatic diseases 73 (5), 897-901, 2014 | 68 | 2014 |
| Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up R Topaloğlu, NA Ayaz, HR Waterham, A Yüce, F Gumruk, Ö Sanal Clinical rheumatology 27, 1317-1320, 2008 | 67 | 2008 |
| The clinical spectrum of Henoch–Schönlein purpura in children: a single-center study ŞG Karadağ, A Tanatar, HE Sönmez, F Çakmak, A Kıyak, S Yavuz, ... Clinical rheumatology 38, 1707-1714, 2019 | 55 | 2019 |
| Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study İ Karacan, A Balamir, S Uğurlu, AK Aydın, E Everest, S Zor, MÖ Önen, ... Rheumatology international 39 (5), 911-919, 2019 | 55 | 2019 |
| Comorbidities and phenotype–genotype correlation in children with familial Mediterranean fever NA Ayaz, A Tanatar, ŞG Karadağ, M Çakan, G Keskindemirci, HE Sönmez Rheumatology International 41 (1), 113-120, 2021 | 47 | 2021 |
| An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud’s phEnomenon (SUNSHINE survey) F Ingegnoli, N Ughi, G Dinsdale, A Orenti, P Boracchi, Y Allanore, ... Rheumatology international 37, 1879-1890, 2017 | 46 | 2017 |
| Behçet disease: treatment of vascular involvement in children S Ozen, Y Bilginer, N Besbas, NA Ayaz, A Bakkaloglu European journal of pediatrics 169, 427-430, 2010 | 46 | 2010 |
| Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial HI Brunner, I Foeldvari, E Alexeeva, NA Ayaz, IC Penades, O Kasapcopur, ... Annals of the rheumatic diseases 82 (1), 154-160, 2023 | 42 | 2023 |
